AntiPARKINSONISM Flashcards

1
Q

a chronic, progressive degenerative disorder affecting the dopamine – producing neurons in the basal ganglia

A

Parkinson’s Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathophysiology of parkinson’s dse?

A

reduction: of dopamine in the basal ganglia of the brain à normal

     **    balance of cholinergic** and **dopaminergic neurons is lost**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What age is Parkinson’s dse common?

A

common among people between 45 and 65 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What gender is greatly affected in Parkinson’s dse?

A

men and women are equally affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the early signs and symptoms of Parkinson’s DSe?

A
  1. muscle rigidity (cogwheel rigidity)
    1. tremor at rest (pill – rolling tremor)
    2. loss of voluntary muscle movement (akinesia)
    3. abnormal slowness of movements (bradykinesia)
    4. difficulty of movement (dyskinesia)
    5. expressionless face (masked facie)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the late signs and symptoms of Parkinson’s DSe?

A
  1. depression and emotional changes
    1. sleep problems
    2. memory loss and slow thinking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the Goal of thex for Parkinson’s dse?

A

restore the balance between dopamine and acetylcholine:

 1. increasing activity of dopamine **(dopaminergics)**
 2. blocking the action of acetylcholine **(anticholinergics)**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 3 sub categories for anti-parkinsonism agents?

A
  • Dopaminergic Agents
  • Anticholinergic Agents
  • Neuroprotective Agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are Dopaminergic Agents?

A
    • amantadine,
  • bromocriptine,
  • levodopa,
  • levodopa – carbidopa,
  • pergolide,
  • pramipexole,
  • ropinirole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anticholinergic Agents

A
  • benztropine,
  • biperiden,
  • diphenhydramine,
  • ethopropazine,
  • procyclidine,
  • trihexyphenidyl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neuroprotective Agents

A
  • selegiline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Geriatric Considerations: Anticholinergics

A
  • Elderly patients are at risk for the development of the side effects of anticholinergics (dry mouth, constipation, impaired thought processes and urinary retention).
  • Anticholinergics are contraindicated in patients with narrow – angle glaucoma or with a history of urinary retention.
  • Elderly patients taking anticholinergic agents may experience paradoxical reactions (excitement, confusion, irritability
  • Overheating may occur in patients taking anticholinergics.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Geriatric Considerations: Levodopa

A
  • Levodopa should be used cautiously in elderly patients with history of cardiac, renal, hepatic, endocrine, pulmonary, ulcers or psychiatric disease.
  • Elderly patients taking levodopa are at risk for confusion.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is Levodopa – carbidopa often started at low dose?

A

because of the** increased sensitivity of the aged patient to these medications.**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dopaminergic Agents MOA acts by 3 ways:

A
  1. stimulation of dopamine release (indirect acting)
  2. increasing brain levels of dopamine (replacement)
  3. direct stimulation of dopaminergic centers (direct acting)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

stimulation of dopamine release **(indirect acting): **

A

** a**mantadine,

entacapone

” Alber Einstein School INDIRECT science highschool”

17
Q

increasing brain levels of dopamine (replacement):

A

levodopa,

         levodopa – carbidopa
18
Q

direct stimulation of dopaminergic centers (direct acting):

A

** bromocriptine, pergolide, ropinirole **

Bro per Role ang direct acting dapat”

19
Q

precursor of dopamine;

crosses the blood brain barrier

A

Levodopa

20
Q

What are the contraindications of Levodopa?

A
  1. hypersensitivity
    2. narrow – angle glaucoma
    3. history of melanoma
    4. psychotic patients
21
Q

What are the route of administration of Levodopa?

A

only available in oral form

22
Q

What is the plasma half-life of levodopa?

A

Plasma half life is 1 – 3 hours

23
Q

Levodopa is usually in combination with

A

Usually given in combination with carbidopa

24
Q

Levodopa’s best results are obtained when?

A

Best results are obtained in the in the first few months of treatment due to the need of reducing the dose

25
Q

Levodopa is contraindicated to:

A
  • psychotic patients
  • angle-closure glaucoma
26
Q

Levodopa has special precaution to:

A
  • PUD
  • malignant melanoma
27
Q

What are the adverse effects of levodopa?

A

GI – anorexia, nausea and vomiting

          CV – tachycardia, postural hypotension

          Musculo-skeletal – Dyskinesia

          Behavioral effects – depression, anxiety, agitation

         Others –mydriasis, blood dyscrasias, hot flushes
28
Q

may alleviate some of the neurologic and** behavioral adverse** effects of levodopa

A

Drug holidays

; 3-21 days

29
Q

Levodopa has drug interactions to?

A

Drug interactions:

  1. Pyridoxine (Vitamin B6)enhance extracerebral metabolism of levodopa à decreased levels à decreased therapeutic effect
  2. Should not be given with MAOI or **within 2 weeks of discontinuance à hypertensive crisis **
30
Q
A